Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06136832 · ClinicalTrials.gov registry record · NA
Pneumonia Vaccine Education Intervention Study
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
NCT06136832 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 141 participants.
The verdict
NCT06136832, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
Study Summary
The goal of this interventional clinical trial is to investigate the impact of medicine and pharmacy-led education on patient acceptance rates of Prevnar 20 pneumonia vaccination in patients eligible to receive the vaccine. The education intervention and subsequent option to get the vaccine will be done while the patient is admitted to inpatient care, prior to discharge. The main questions the study aims to answer are: * Will supplemental education about the Prevnar 20 Pneumococcal vaccine influence patient acceptance rates when given a decision to receive it? * Is there any other statistically relevant qualitative reasoning behind the patient's final decision for accepting or refusing the vaccine?
Interventions
- BEHAVIORAL Pneumococcal Vaccine Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2024-05-06 |
| Est. Completion | 2025-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06136832
The ClinicalTrials.gov registry entry for NCT06136832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pneumococcal Vaccine Education is the first listed.
NCT06136832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06136832 about?
NCT06136832 is a clinical study titled "Pneumonia Vaccine Education Intervention Study". The goal of this interventional clinical trial is to investigate the impact of medicine and pharmacy-led education on patient acceptance rates of Prevnar 20 pneumonia vaccination in patients eligible to receive the vaccine. The education intervention and subsequent option to get the vaccine will be ...
What is the current status of trial NCT06136832?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2024-05-06. Estimated completion is 2025-01-26.
What interventions are being tested in trial NCT06136832?
The interventions under investigation include: Pneumococcal Vaccine Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT06136832?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.